methylnitrosourea has been researched along with methylselenic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ganther, HE; Ip, C; Thompson, HJ; Zhu, Z | 1 |
| Gopalakrishna, R; Gottlieb, SN; Gundimeda, U; Roth, BI; Schiffman, JE | 1 |
2 other study(ies) available for methylnitrosourea and methylselenic acid
| Article | Year |
|---|---|
In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Carcinogens; Comet Assay; Female; Glutathione Peroxidase; Liver; Lyases; Mammary Neoplasms, Experimental; Methylnitrosourea; Mice; Neoplasms, Experimental; Organoselenium Compounds; Rats; Rats, Sprague-Dawley; Selenium; Thioredoxin-Disulfide Reductase; Tissue Distribution; Tumor Cells, Cultured | 2000 |
Negation of the cancer-preventive actions of selenium by over-expression of protein kinase Cepsilon and selenoprotein thioredoxin reductase.
Topics: Anticarcinogenic Agents; Cell Line, Tumor; Humans; Indoles; Male; Maleimides; Methylnitrosourea; Neoplasm Invasiveness; Organoselenium Compounds; Prostatic Neoplasms; Protein Kinase C-epsilon; Thioredoxin-Disulfide Reductase | 2009 |